[Rx2021] Fw: WVU DI residency
Skledar, Susan Jean
sjs15 at pitt.edu
Fri Jan 22 16:26:26 EST 2021
Hello P4s,
See below for information on a DI Residency at WVU Health. It does not go through the ASHP Match.
Prof. Skledar
Sue Skledar, RPh, MPH, FASHP
Director of Experiential Learning
Professor, Department of Pharmacy & Therapeutics
University of Pittsburgh School of Pharmacy
228 Salk Hall
3501 Terrace Street
Pittsburgh, PA 15261
412-648-1504
sjs15 at pitt.edu<mailto:sjs15 at pitt.edu>
________________________________
From: Abate, Marie <mabate at hsc.wvu.edu>
Sent: Wednesday, January 20, 2021 2:42 PM
To: Skledar, Susan Jean <sjs15 at pitt.edu>
Subject: WVU DI residency
Dear Sue,
I hope all is well with you there and you are staying safe in the midst of the pandemic and this most unusual academic year so far! As in the past, I wanted to send you information about our drug information residency program and would appreciate it if you could, once again, share this information with your P4 students or any PGY1 residents you might work with. The program is our Specialty Drug Information Residency we have in conjunction with Viatris (formerly Mylan Labs, now part of Pfizer), which we will continue to offer. We do not go through the ASHP matching program, which is important that prospective students be aware of.
If you know of anyone who might be interested in our program, please forward the attached brochure to them. The deadline for applications is February 10. More information can be found on our web site at:
http://pharmacy.hsc.wvu.edu/departments-centers/wv-center-for-drug-and-health-information/residency-information/<https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fpharmacy.hsc.wvu.edu%2Fdepartments-centers%2Fwv-center-for-drug-and-health-information%2Fresidency-information%2F&data=04%7C01%7Crx2021%40list.pitt.edu%7C3f530c6c170c4dacd50308d8bf1c76bb%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C637469476271212237%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=dZfWxtY8WLl8SvvSwKOxA9%2BXZcQ2nWDFgXTKNFmBpDg%3D&reserved=0>
Specialty Residency: Drug Information | School of Pharmacy<https://na01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fpharmacy.hsc.wvu.edu%2Fdepartments-centers%2Fwv-center-for-drug-and-health-information%2Fresidency-information%2F&data=04%7C01%7Crx2021%40list.pitt.edu%7C3f530c6c170c4dacd50308d8bf1c76bb%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1%7C0%7C637469476271212237%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=dZfWxtY8WLl8SvvSwKOxA9%2BXZcQ2nWDFgXTKNFmBpDg%3D&reserved=0>
pharmacy.hsc.wvu.edu
West Virginia Center for Drug and Health Information/Mylan, Inc. Residency Brochure: Drug Information Residency Brochure; Application Materials: Drug Information ...
I am also available to answer any questions from students or residents.
As before, thank you very much!
Marie
Marie A. Abate, BS, PharmD
Professor of Clinical Pharmacy
Assistant Dean for Assessment and Strategic Planning
West Virginia University School of Pharmacy
1124 Health Sciences North
Morgantown, WV 26506-9520
(304) 293-1463 Phone
(304) 293-7672 Fax
mabate at hsc.wvu.edu
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and/or privileged information. Any unauthorized review, use, disclosure or distribution by anyone other than the intended recipient(s) is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://list.pitt.edu/pipermail/rx2021/attachments/20210122/0d447c2e/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: residency-brochure-2021.pdf
Type: application/pdf
Size: 6434876 bytes
Desc: residency-brochure-2021.pdf
URL: <https://list.pitt.edu/pipermail/rx2021/attachments/20210122/0d447c2e/attachment-0001.pdf>
More information about the Rx2021
mailing list